dna alkylating

CEP-40125 (RXDX-107) 是一种 DNA 烷基剂，可用于研究晚期实体瘤。

Altretamine (ENT-50852) 是一种具有抗肿瘤活性的烷化剂。

Lomustine (NSC-79037) 是一种具有抗肿瘤活性的 DNA 烷化剂。

Satraplatin (BMS182751) 是一种烷化剂 ，是一种口服的抗肿瘤铂 (IV) 复合物，具有广泛的抗肿瘤效果。

Oxaliplatin (L-OHP) 是一种 DNA 烷化剂，一种 DNA 合成抑制剂。Oxaliplatin 会导致 DNA 交联损伤，阻止 DNA 复制和转录并导致细胞死亡。Oxaliplatin 可以诱导细胞自噬。

Temozolomide (TMZ) 是一种 DNA 烷基化剂，具有血脑屏障渗透性和口服活性。Temozolomide 具有抗肿瘤活性和抗血管生成活性，还可以诱导细胞凋亡和自噬。 Temozolomide 在酸性条件下稳定，在中性或微碱性条件下会发生水解。

Semustine 是一种 DNA 烷化剂，是一种癌症化疗化合物，在接受辅助化疗的恶性黑色素瘤患者中具有肾毒性，可用于辅助治疗白血病。

Ecomustine 是一种水溶性亚硝基脲糖，来源于氨基乙酸，具有烷基化活性。Ecomustine 是一种新型抗肿瘤化合物，它使DNA 烷基化并交联，从而抑制复制和转录，导致细胞增殖减少。

Sarmustine (SarCNU) 是一种具有抗癌活性的烷化剂，通过 p53 依赖性和 p53 非依赖性途径抑制前列腺癌细胞的生长。Sarmustine 在体外介导 P140K 甲基鸟嘌呤-DNA-甲基转移酶转导的人 CD34(+)细胞的选择。

Canfosfamide Hydrochloride 是一种改性谷胱甘肽类似物的盐酸盐，具有潜在的抗肿瘤活性。canfofamide 可被谷胱甘肽s -转移酶P1-1选择性激活，转化为与肿瘤细胞DNA 亲核中心形成共价键的烷基化代谢物，从而诱导细胞应激反应和细胞毒性，减少肿瘤增殖。

Bendamustine hydrochloride (EP-3101) 是一种嘌呤类似物，是一种 DNA 交联剂。它可激活 DNA 损伤反应和细胞凋亡，有烷基化，抗癌和抗代谢作用。

Cyclophosphamide hydrate 是一种 DNA 烷化剂，一种 DNA 合成抑制剂。Cyclophosphamide hydrate 具有抗肿瘤活性、免疫抑制活性等。

Methoxyamine HCl (Methoxyamine) 与脱嘌呤 脱嘧啶 (AP) DNA 损伤位点共价结合并抑制碱基切除修复 (BER)，这可能导致 DNA 链断裂和细胞凋亡增加。 Methoxyamine 是一种具有潜在佐剂活性的口服生物可利用的小分子抑制剂。该药剂可增强烷化剂的抗肿瘤活性。

N-Nitroso-N-methylurea 是一种具有烷基化、致癌和致突变特性的亚硝基脲化合物。它靶向多种动物器官，可引起各种癌症和变性疾病，可用于重氮甲烷合成。

Aniline-MPB-amino-C3-PBD is a cytotoxic agent comprised of the non-alkylating group. It is a sequence-selective DNA minor-groove binding agent.

(+)-CBI-CDPI1, an enhanced functional analog of CC-1065, is a DNA alkylating agent and an antibody-drug conjugate (ADCs) toxin.

DC1 is an ADC cytotoxin, similar to the small groove-binding DNA alkylating agent CC-1065. DC1 can be used to synthesize antibody-drug conjugates targeted to the treatment of cancer. DC1Sme is a DC1 derivative with IC50 values of Ramos, Namalwa, HL60 s

DC1 can be used to synthesize antibody-drug conjugates targeted to the treatment of cancer, is an ADC cytotoxin, similar to the small groove-binding DNA alkylating agent CC-1065.

DC10SMe is a DNA alkylating agent that can be used in the synthesis of antibody-drug conjugates (ADC). The IC50 of DC10SMe for Ramos, Namalwa and HL60 s cancer cells were 15 pM, 12 pM and 12 pM, respectively.

DC41 is a derivative of DC1. DC1 is a simplified analogue of CC-1065, an antibody conjugate of cytotoxic DNA alkylating agents, used for targeted treatment of cancer.

The IC50s of DC4SMe on Ramos, Namalwa and HL60 s cancer cells were 1.9 nM, 2.9 nM and 1.8 nM, respectively. DC4SMe can be used for targeted therapy of tumors. DC4SMe is a phosphate prodrug of the cytotoxic DNA alkylating agent DC4 and can be used in the

DGN462 is an effective DNA alkylating agent with anti-tumor activity, as in acute myeloid leukemia (AML). DGN462 can be used as a cytotoxic component of antibody-drug conjugates (ADCs).

Dimethyl-SGD-1882 (Dimethyl-PBD dimer) is a highly efficient DNA alkylating agent used as an antibody-drug conjugate (ADC) cytotoxin, inhibiting DNA replication.

Duocarmycin GA, an antibody drug conjugate (ADC) toxin and a DNA alkylating agent, effectively targets and binds in the minor groove of DNA. It is particularly potent against multi-drug resistant cell lines, offering a strategic approach in combating resistance.